SEROUSSI YAIR 4
4 · Enlight Renewable Energy Ltd. · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Enlight (ENLT) Vice Chair Yair Seroussi Exercises Options, Sells Shares
What Happened
- Yair Seroussi, Vice Chairman of Enlight Renewable Energy Ltd. (ENLT), exercised 16,000 option/derivative-based awards on 2026-05-28 (cost $23.22/share, total $371,520). All 16,000 resulting shares were issued; 3,964 were retained by the company to cover the exercise price/tax withholding (value $405,279) and 12,036 shares were sold in an open-market sale at $102.24/share for proceeds of $1,230,561. The filing also lists a related derivative conversion entry at $0.00, reflecting issuance/conversion mechanics.
Key Details
- Transaction date: May 28, 2026. Form 4 filed June 1, 2026 (timely within the 2-business-day requirement).
- Exercise: 16,000 shares @ $23.22 = $371,520 (exercise price reported in NIS 71.89, converted to USD; footnote F1).
- Withholding: 3,964 shares retained by the company @ $102.24 = $405,279 to cover exercise/taxes (footnote F3).
- Open-market sale: 12,036 shares @ $102.24 = $1,230,561 (sale price reported in NIS 290.35, converted to USD; footnote F4).
- Shares owned after the transactions are not specified in the provided excerpt of the filing.
- Relevant footnotes: conversion rates for NIS→USD (F1, F4), withholding mechanics (F3), and details on outstanding/contingent awards (RSUs/PSUs and option grants referenced in F2, F5, F7, F9). Some derivative/award entries are informational per the filing (F8).
Context
- This was effectively a cashless exercise: options were exercised and the company withheld shares to cover the exercise price/taxes, with the remaining shares sold in the open market. That pattern is common for executives monetizing vested option value and does not by itself imply a change in view on the company.
- For retail investors, purchases by insiders can be more informative than routine exercises/sales; in this case the activity mostly monetized gains from vested options rather than indicating a fresh insider buy.
Insider Transaction Report
Form 4
SEROUSSI YAIR
DirectorOther
Transactions
- Exercise/Conversion
Ordinary shares, NIS 0.1 par value per share
[F1][F2]2026-05-28$23.22/sh+16,000$371,520→ 30,233 total - Tax Payment
Ordinary shares, NIS 0.1 par value per share
[F3][F4][F2]2026-05-28$102.24/sh−3,964$405,279→ 26,269 total - Sale
Ordinary shares, NIS 0.1 par value per share
[F4][F2]2026-05-28$102.24/sh−12,036$1,230,561→ 14,233 total - Exercise/Conversion
Stock Options (right to buy)
[F1][F5]2026-05-28−16,000→ 0 totalExercise: $23.22Exp: 2028-09-30→ Ordinary shares, NIS 0.1 par value per share (16,000 underlying)
Holdings
- 51,574
Stock Options (right to buy)
[F6][F7][F8]Exercise: $27.33Exp: 2032-10-01→ Ordinary shares, NIS 0.1 par value per share (51,574 underlying) - 11,339
Performance-Based RSUs
[F9][F8]→ Ordinary shares, NIS 0.1 par value per share (11,339 underlying)
Footnotes (9)
- [F1]Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- [F2]Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
- [F3]These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
- [F4]Represents a transaction price of NIS 290.35, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
- [F5]Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.
- [F6]Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- [F7]Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029.
- [F8]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F9]Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
Signature
By: /s/ Helit Megido as attorney-in-fact for Yair Seroussi|2026-06-01